Foresee Pharmaceuticals Valuation
| 6576 Stock | TWD 77.70 0.10 0.13% |
At this time, the firm appears to be overvalued. Foresee Pharmaceuticals shows a prevailing Real Value of NT$65.25 per share. The current price of the firm is NT$77.7. Our model computes the value of Foresee Pharmaceuticals from reviewing the firm fundamentals such as Profit Margin of (1.57) %, current valuation of 10.39 B, and Shares Outstanding of 118.12 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Foresee Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Foresee Pharmaceuticals is based on 3 months time horizon. Increasing Foresee Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Foresee stock is determined by what a typical buyer is willing to pay for full or partial control of Foresee Pharmaceuticals Co. Since Foresee Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Foresee Stock. However, Foresee Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 77.7 | Real 65.25 | Hype 77.7 |
The intrinsic value of Foresee Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Foresee Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Foresee Pharmaceuticals Co helps investors to forecast how Foresee stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Foresee Pharmaceuticals more accurately as focusing exclusively on Foresee Pharmaceuticals' fundamentals will not take into account other important factors: Foresee Pharmaceuticals Total Value Analysis
Foresee Pharmaceuticals Co is presently anticipated to have takeover price of 10.39 B with market capitalization of 12.58 B, debt of 0, and cash on hands of 1.34 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Foresee Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.39 B | 12.58 B | 0 | 1.34 B |
Foresee Pharmaceuticals Investor Information
About 35.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 4.53. Foresee Pharmaceuticals had not issued any dividends in recent years. The entity had 1108:1091 split on the 27th of November 2020. Based on the key indicators related to Foresee Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Foresee Pharmaceuticals Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Foresee Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Foresee Pharmaceuticals has an asset utilization ratio of 13.77 percent. This indicates that the Company is making NT$0.14 for each dollar of assets. An increasing asset utilization means that Foresee Pharmaceuticals Co is more efficient with each dollar of assets it utilizes for everyday operations.Foresee Pharmaceuticals Ownership Allocation
Foresee Pharmaceuticals holds a total of 118.12 Million outstanding shares. Foresee Pharmaceuticals Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Foresee Pharmaceuticals Profitability Analysis
The company reported the revenue of 226.03 M. Net Loss for the year was (569.27 M) with profit before overhead, payroll, taxes, and interest of 175.08 M.About Foresee Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Foresee Pharmaceuticals. We calculate exposure to Foresee Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Foresee Pharmaceuticals's related companies.Foresee Pharmaceuticals Co., Ltd., clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in Taiwan and Europe. Foresee Pharmaceuticals Co., Ltd. was founded in 2013 and is headquartered in Taipei, Taiwan. FORESEE PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
8 Steps to conduct Foresee Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Foresee Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Foresee Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Foresee Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Foresee Pharmaceuticals' revenue streams: Identify Foresee Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Foresee Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Foresee Pharmaceuticals' growth potential: Evaluate Foresee Pharmaceuticals' management, business model, and growth potential.
- Determine Foresee Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Foresee Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Foresee Stock Analysis
When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.